Characterization of factors affecting the release of low-solubility drug from prolonged release tablets

被引:27
作者
Kincl, M
Vrecer, F
Veber, M
机构
[1] Krka Dd, R&D, Physicochem Dev Dept, Novo Mesto 8501, Slovenia
[2] Krka Dd, R&D, New Formulat Res Dept, Novo Mesto 8501, Slovenia
[3] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia
关键词
prolonged release tablets; ionic strengths; pH; fractional factorial designs; two-level designs;
D O I
10.1016/j.aca.2003.09.050
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Diclofenac sodium (2-[(2,6-dichlorophenyl)amino]benzeneacetic acid monosodium salt) was investigated as a low-solubility drug and Naklofen((R)) retard prolonged release tablets, containing 100mg of diclofenac sodium as a prolonged release lipophilic matrix system using factorial design approach. First, the solubility characteristics of diclofenac sodium in aqueous media with various ionic strengths, ionic compositions and pH in the range of 1-8 were determined. The obtained results showed that the solubility of diclofenac sodium depends mainly on pH of the aqueous medium and less on the composition and ionic strength of the medium. Next, the estimation of the effects of six different factors (type of the dissolution apparatus, rotation speeds of the stirring elements, pH, ionic strengths of dissolution medium, the applied salt, and the producer of the on-line connected dissolution apparatus and UV spcctrophotometer) on the release of diclofenac sodium, using the two-level six-factorial design was investigated. It was found that rotation speeds of the stirring elements, pH, and ionic strengths of the dissolution medium have a significant impact on the drug release and should be further followed in future drug release analyses. The advantages of the factorial design approach are obvious in this work. It is a very economic way of obtaining the maximum amount of information in a short period of time, especially in the case of prolonged release formulations where each experiment requires at least 24 h. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 13 条
[1]  
Adeyeye C.M., 1990, Analytical Profiles of Drug Substances, P123
[2]   pH-metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods [J].
Avdeef, A ;
Berger, CM ;
Brownell, C .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :85-89
[3]   Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties [J].
Bloomfield, MS ;
Butler, WC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 206 (1-2) :55-61
[4]  
Bolton S, 1990, PHARM STAT PRACTICAL, P308
[5]  
DEMIRTURK E, 2002, P 4 WORLD M PHARM BI
[6]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[7]  
*EMEA CPMP, 1999, NOT GUID QUAL MOD RE
[8]   Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract (Reprinted from Advanced Drug Delivery reviews, vol 25, pg 3-14, 1997) [J].
Hörter, D ;
Dressman, JB .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :75-87
[9]  
Parojcic J, 2001, PHARM IND, V63, P774
[10]  
Sabnis S, 1997, Pharm Dev Technol, V2, P243, DOI 10.3109/10837459709031444